Trials / Completed
CompletedNCT04665700
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated
Safety, Tolerability and Pharmacokinetics of Single and Multiple Rising Doses of BI 764198 in Japanese Healthy Male Subjects (Double-blind, Randomised, Placebo-controlled Within Dose Groups, Parallel Group Design)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The main objectives of this trial are to investigate safety and tolerability of BI 764198 in healthy male subjects following oral administration of single dose and multiple rising doses per day over 14 days. Secondary objectives are the exploration of pharmacokinetics (PK) of BI 764198 after single and multiple oral dosing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 764198 | BI 764198 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2021-02-06
- Primary completion
- 2021-10-16
- Completion
- 2021-10-16
- First posted
- 2020-12-14
- Last updated
- 2021-11-01
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04665700. Inclusion in this directory is not an endorsement.